Design or refine hiPSC/ES-cell differentiation pipelines into ventricular, atrial or pacemaker-like cardiomyocytes, including maturation strategies, quality metrics, and assay selection for safety and efficacy studies.

Build organoid systems for arrhythmia, heart failure, and congenital disease modeling. We advise on model architecture, readouts (optical mapping, MEA imaging), and data interpretation for translational programs.

Integrate stem cell data into preclinical packages, assist with experimental sections of grants and regulatory documents, and provide independent scientific review for due diligence or partnership evaluations.